1. U.S. Food and Drug Administration. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Fed Reg2008;73:30831.

2. PowrieRO. Principles for drug prescribing in pregnancy. InRosene‐MontellaK, KellyE, BarbourLA, LeeRV(eds). Medical Care of the Pregnant Patient. 2nd ed. Philidelphia, PA: ACP Press; 2008: 18–32.

3. Accessed 03.06.2015: http://www.fda.gov/drugs/developmentapprovalprocess/developmentresources/labeling/ucm425415.htm

4. Food and Drug Administration, HHS. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule. Fed Regist2014;79:72063.

5. RamozLL, Patel‐ShoriNM. Recent changes in pregnancy and lactation labeling: retirement of risk categories. Pharmacotherapy2014;34:389. CrossRef

6. BarakS, Oettinger‐BarakO, OettingerM, et al.Common oral manifestations during pregnancy: a review. Obstet Gynecol Surv2003;58:624. CrossRef

7. Van ThielDH, GavalerJS, JoshiSN, et al.Heartburn of pregnancy. Gastroenterology1977;72:666.

8. BaronTH, RamirezB, RichterJE. Gastrointestinal motility disorders during pregnancy. Ann Intern Med1993;118:366. CrossRef

9. FisherRS, RobertsGS, GrabowskiCJ, et al.Altered lower esophageal sphincter function during early pregnancy. Gastroenterology1978;74:1233.

10. NaglerR, SpiroHM. Heartburn in late pregnancy. Manometric studies of esophageal motor function. J Clin Invest1961;40:954. CrossRef

11. HabrF, RakerC, LinCL, et al.Predictors of gastroesophageal reflux symptoms in pregnant women screened for sleep disordered breathing: a secondary analysis. Clin Res Hepatol Gastroenterol2012;37:93. CrossRef

12. SchadeRR, PelekanosMJ, TauxeWN, et al.Gastric empyting during pregnancy (abstract). Gastroenterology1984;86:A1234.

13. DavisonJS, DavisonMC, HayDM. Gastric emptying time in late pregnancy and labour. J Obstet Gynaecol Br Commonw1970;77:37. CrossRef

14. KochKL, SternRM, VaseyM, et al.Gastric dysrhythmias and nausea of pregnancy. Dig Dis Sci1990;35:961. CrossRef

15. RichterJE. Gastroesphageal reflux during pregnancy. Gastroenterol Clin North Am2003;32:235. CrossRef

16. MahadevanUGastrointestinal medications in pregnancy. Best Pract Res Clin Gastro2007;21:849. CrossRef

17. GordonMV, McMahonLP, HamblinPS. Life‐threatening milk‐alkali syndrome resulting from antacid ingestion during pregnancy. [see comment]. Med J Aust2005;182:350.

18. RichterJE. Review article: the management of heartburn in pregnancy. Aliment Pharmacol Ther2005;23:749. CrossRef

19. LindowSW, RegnellP, SykesJ, et al.An open‐label multi‐center study to assess he safety and efficacy of a novel reflux supplement (gasviscon advance) in the treatment of heartburn in pregnancy. Int J Clin Pract2003;57:175.

20. SrugalaV, BassainJ, SwalesVS, et al.Assessment of the safety and efficacy of a raft‐forming alginate reflux suppressant (liquid gaviscon) for the treatment of heartburn during pregnancy. Obstet Gynecol2012;2012:481870.

21. RanchetG, GangemiO, PetroneM. Sucralfate in the reatment of gravid pyrosis. G Ital Ostet Ginecol1990;12:1.

22. AlbibiR, McCallumRW. Metoclopramide: pharmacology and clinical application. Ann Intern Med1983;98:86. CrossRef

23. MageeLA, InocenianG, KambojtR, et al.Safety of first trimester exposure to histamine H2 blockers: a prospective cohort study. Dig Dis Sci1996;41:1145. CrossRef

24. GillSK, O'BrienL, KorenG. The safety of histamine 2 (H2) blockers in pregnancy: a meta‐analysis. Dig Dis Sci2009;54:1835. CrossRef

25. LarsonJD, PatatanianE, MinerPBJr. Double‐blind, placebo‐controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy. Obstet Gynecol1997;90:83. CrossRef

26. SavarinoV, GiastiM, ScalabriniP, et al.Famotidine has no significant effect on gonadal function in men. Gastroenterol Clin Biol1988;12:19.

27. Prilosec (product information). Wilmington, DE, USA: AstraZeneca, 2004.

28. GillSK, O'BrienL, EinarsonTR, et al.The safety of proton pump inhibitors (PPIs) in pregnancy: a meta‐analysis. Am J Gastroenterol2009;104:1541. CrossRef

29. PasternakB, HviidA. Use of proton‐pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med2010;363:2114. CrossRef

30. CunninghamFG, GantNF, LevenoKJ, et al.Gastrointestinal disorders. William's obstetrics. New York: McGraw‐Hill; 2001: 1273.

31. HessLW, MorrisonJC, HessDB. General medical disorders during pregnancy. In: DeCherneyAH, PernollML(eds). Current Obstetric and Gynecologic Diagnosis and Treatment Norwalk (CT). Norwalk, CT: Appleton & Lange; 1994.

32. JonesPF, McEwanAB, BernardRM. Hemorrhage and perforation complicating peptic ulcer in pregnancy. Lancet1969;2:350. CrossRef

33. RubinPH, JanowitzHD. Digestive tract disorders. In: CohenWR(ed). Cherry and Merkatz's Complications of Pregnancy. Philadelphia: Lippincott Williams & Wilkins; 2000: 305.

34. TietzCA, SpellacyWN. Gastric ulcer associated with pregnancy: a case report and review of peptic ulcers and pregnancy. Lancet1966;86:487.

35. BairdRM. Peptic ulceration in pregnancy: report of a case with perforation. Can Med Assoc J1966;94:L861.

36. CappellMS, SidhomO. A multicenter, multiyear study of the safety and clinical utility of esophagogastroduodenoscopy in 20 consecutive pregnant females with follow‐up of fetal outcome. Am J Gastroenterol1993;88:1900.

37. CappellMS. Gastric and duodenal ulcers during pregnancy. Gastroenterol Clin North Am2003;32:263. CrossRef

38. CappellMS, ColonVJ, SidhomO. A study of eight medical centers of the safety and clinical efficacy of esophagogastroduodenoscopy in 83 pregnant females with follow‐up of fetal outcome with comparison control groups. Am J Gastroenterol1996;91:348.

39. ChenY‐H, LinH‐C, LouH‐Y. Increased risk of low birthweight, infants small for gestational age, and preterm delivery for women with peptic ulcer. Am J Obstet Gynecol2010;202:164.e1. CrossRef

40. MahadevanU, KaneSV. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterol2006;131:283. CrossRef

41. ShapiroS, SiskindV, MonsonRR, et al.Perinatal mortality and birth‐weight in relation to aspirin taken during pregnancy. Lancet1976;1:1375. CrossRef

42. O'BrienB, ZhouQ. Variables related to nausea and vomiting during pregnancy. Birth1995;22:93. CrossRef

43. DoddsL, FellDB, JosephKS, et al.Outcome of pregnancies complicated by hyperemesis gravidarum. Obstet Gynecol2006;107:285. CrossRef

44. GolbergD, SzilagyiA, GravesL. Hyperemesis gravidarum and Helicobacter pylori infection: a systemic review. Obstet Gynecol2007;110:695. CrossRef

45. KlebanoffMA, KoslowePA, KaslowR, et al.Epidemiology of vomiting in early pregnancy. Obstet Gynecol1985;66:612.

46. BrandesJM. First trimester nausea and vomiting as related to outcome of pregnancy. Obstet Gynecol1967;30:427.

47. LacroixR, EasonE, MelzackR. Nausea and vomiting during pregnancy: a prospective study of its frequency, intensity, and patterns of change. Am J Obstet Gynecol2000;182:931. CrossRef

48. GadsbyR, Barnie‐AdsheadA, JaggerC. Pregnancy nausea related to women's obstretic and personal histories. Gynecol Obstet Invest1997;43:108. CrossRef

49. WhiteheadS, HoldenW, AndrewsP. Maternal susceptibility to nausea and vomiting of pregnancy: is the vestibular system involved?Am J Obstet Gynecol2002;186:S204. CrossRef

50. HeinrichsL. Linking olfaction with nausea and vomiting of pregnancy, recurrent abortion, hyperemesis gravidarum, and migraine headache. Am J Obstet Gynecol2002;186:S215. CrossRef

51. BroussardCN, RichterJE. Nausea and vomiting of pregnancy. Gastroenterol Clin1998;27:123. CrossRef

52. FejzoMS, InglesSA, WilsonM, et al.High prevalence of severe nausea and vomiting of pregnancy and hyperemesis gravidarum among relatives of affected individuals. Eur J Obstet Gynecol Reprod Biol2008;141:13. CrossRef

53. FellDB, DoddsL, JosephKS, et al.Risk factors for hyperemesis gravidarum requiring hospital admission during pregnancy. Obstet Gynecol2006;107:277. CrossRef

54. KallenB. Hyperemesis gravidarum during pregnancy and delivery outcome: a registry study. Eur J Obstet Gynecol Reprod Biol1987;26:291. CrossRef

55. SchiffM, ReedS, DalingJ. The sex ratio of pregnancies complicated by hospitalization for hyperemesis gravidarum. BJOG2004;111:27. CrossRef

56. NiebylJR. Nausea and vomiting in pregnancy. N Engl J Med2010;363:1544. CrossRef

57. DavisM. Nausea and vomiting of pregnancy: an evidence‐based review. Perinat Neonatal Nurs2004;18:312. CrossRef

58. GoodwinTM, MontoroM, MestmanJH, et al.The role of chorionic‐gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab1992;75:1333.

59. SoulesMR, HughsCL, GarciaJA, et al.Nausea and vomiting of pregnancy: role of human chorionic gonadotropin and 17‐hydroxyprogesterone. Obstet Gynecol1980;55:696.

60. KuscuN, KoyuncuF. Hyperemesis gravidarum: current concepts and management. Postgrad Med J2002;78:76. CrossRef

61. EvansAJ, LiTC, SelbyC, et al.Morning sickness and thyroid function. Br J Obstet Gynaecol1986;93:520. CrossRef

62. GoodwinTM, HershmannJM. Hyperthyroidism due to inappropriate production of human chorionic gonadotropin. Clin Obstet Gynecol1997;40:32. CrossRef

63. SandvenI, AbdelnoorM, NesheimBI, et al.Helicobacter pylori infection and hyperemesis gravidarum: a systematic review and meta‐analysis of case‐control studies. Acta Obstet Gynecol Scand2009;88:1190. CrossRef

64. VerbergMFG, GillottDJ, Al‐FardanN, et al.Hyperemesis gravidarm, a literature review. Hum Reprod Update2005;11:527. CrossRef

65. WeyermannM, BrennerH, AdlerG, et al.Helicobacter pylori infection and the occurrence and severity of gastrointestinal symptoms during pregnancy. Am J Obstet Gynecol2003;1989:526. CrossRef

66. WuC‐Y, TsengJ‐J, ChouM‐M, et al.Correlation between Helicobacter pylori infection and gastrointestinal symptoms in pregnancy. Adv Ther2000;17:152. CrossRef

67. BrzanaRJ, KochKL. Intractable nausea presenting as gastroesophageal reflux disease. Ann Intern Med1997;126:704. CrossRef

68. SemmensJP. Female sexuality and life situations: an etiologic psycho‐socio‐sexual profile of weight gain and nausea and vomiting of pregnancy. Obstet Gynecol1971;38:555. CrossRef

69. SimpsonSW, GoodwinTM, RobinsSB, et al.Psychological factors and hyperemesis gravidarum. J Womens Health Gend Based Med2001;10:471. CrossRef

70. MunchS. Women's experiences with a pregnancy complication: causal explanations of hyperemesis gravidarum. Soc Work Health Care2002;36:519. CrossRef

71. GodseyRK, NewmanRB. Hyperemesis gravidarum: a comparison of single and multiple admissions. J Reprod Med1991;36:287.

72. KochKL, FrissoraC. Nausea and vomiting during pregnancy. Gastroenterol Clin N Am2003;32:201. CrossRef

73. GoodwinTM. Hyperemesis gravidarum. Obstet Gynecol Clin N Am2008;35:401. CrossRef

74. JainSK, ShahM, RansonetL, et al.Maternal and neonatal plasma transthyretin (prealbumin) concentrations and birth weight of newborn infants. Biol Neonate1995;68:10. CrossRef

75. WallstedtA, RielyCA, ShaverD, et al.Prevalence and characteristics of liver dysfunction in hyperemesis gravidarum. Clin Res1990;38:970A.

76. KnoxTA, OlansLB. Liver disease in pregnancy. N Engl J Med1996;335:569. CrossRef

77. ConchilloJM, PijnenborgJMA, PeetersP, et al.Liver enzyme elevation induced by hyperemesis gravidarum: aetiology, diagnosis and treatment. Neth J Med2002;60:374.

78. KlebanoffMA, MillsJ. Is vomiting during pregnancy teratogenic?BMJ1986;292:724. CrossRef

79. WeigelRM, WeigelMM. Nausea and vomiting of early pregnancy and pregnancy outcome. A meta‐analytical review. Br J Obstet Gynecol1989;96:1312. CrossRef

80. TiersonFD, OlsenCL, HookEG. Nausea and vomiting of pregnancy and association with pregnancy outcome. Am J Obstet Gynecol1986;155:1017. CrossRef

81. SmithC, CrowtherC, BeilbyJ, et al.The impact of nausea and vomiting on women: a burden of early pregnancy. Aust NZ J Obstet Gynecol2000;4:397. CrossRef

82. BashiriA, NewmannL, MaymonE, et al.Hyperemesis gravidarum: epidemiologic features, complications, and outcome. Eur J Obstet Gynecol Reprod Biol1995;63:135. CrossRef

83. ZhangJ, CaiW. Severe vomiting during pregnancy. Antenatal correlates and fetal outcomes. Epidemiology1991;2:454. CrossRef

84. GrossS, LibrachC, CecuttiA. Maternal weight loss associate with hyperemesis gravidarum: a predictor of fetal outcome. Am J Obstet Gynecol1989;160:906. CrossRef

85. KanayamaN, KhutanS, BelayetHM, et al.Vasospasms of cerebral arteries in hyperemesis gravidarum. Gynecol Obstet Invest1998;46:139. CrossRef

86. TrogstadL, StoltenbergC, MagnusP, et al.Recurrence risk in hyperemesis gravidarum. BJOG2005;112:1641. CrossRef

87. Brunetti‐PierriN, HunterJV, BoerkoelCF. Gray matter heterotopias and brachytelephalangic chondrodysplasia punctata: a complication of hyperemesis gravidarum induced vitamin K deficiency?Am J Med Genet A2007;154:200. CrossRef

88. Eventov‐FriedmanS, KlingerG, ShinwellES. Third trimester fetal intracranial hemorrhage owing to vitamin K deficiency associated with hyperemesis gravidarum. J Pediatr Hematol Oncol2009;31:985. CrossRef

89. EbrahimiN, MaltepeC, BournisssenFG, et al.Nausea and vomiting of pregnancy: using the 24‐hour Pregnancy‐Unique Quantification of Emesis (PUQE‐24) scale. J Obstet Gynaecol Can2009;31:803.

90. PowerZ, CampbellM, KilcoyneP, et al.The Hyperemesis Impact of Symptoms Questionnaire: development and validation of a clinical tool. Int J Nurs Stud2010;47:67. CrossRef

91. LacasseA, ReyE, FerreiraE, et al.Determinants of early medical management of nausea and vomiting of pregnancy. Birth2009;36:70. CrossRef

92. JednakMA, ShadigianEM, KimMS, et al.Protein meals reduced nausea and gastric slow waves dysrhythmic activity in first trimester pregnancy. Am J Physiol1999;277:855.

93. JueckstockJK, KaestnerR, MylonasI. Managing hyperemesis gravidarum: a multimodal challenge. BMC Med2010;8:46. CrossRef

94. HodM, OrvietoR, KaplanB, et al.Hyperemesis gravidarum: a review. J Reprod Med1994;39:605.

95. ACOG. (American College of Obstetrics and Gynecology) practice bulletin: nausea and vomiting of pregnancy. Obstet Gynecol2004;103:803.

96. MahadyG, PendlandS, YunG, et al.Ginger and the gingerols inhibits the growth of CagA+ strains of Helicobacter Pylori. Anticancer Res2003;23:3699.

97. RosenT, VecianaM, MilerH, et al.A randomized controlled trial of nerve stimulation for relief of nausea and vomiting in pregnancy. Obstet Gynecol2003;102:129. CrossRef

98. QuinlanPD, HillDA. Nausea and vomiting of pregnancy. Am Fam Physician2003;68:121.

99. Diclegis (doxylamine succinate and pyridoxine hydrochloride) package insert. Bryn Mawr, PA: Duchesnay USA, Inc; 2013.

100. NiebylJR, GoodwinT. Overview of nausea and vomiting of pregnancy with an emphasis on vitamins and ginger. Am J Obstet Gynecol2002;186:S253. CrossRef

101. NeutelCI, JohansenHL. Measuring drug effectiveness by default: the case of Bendectin. Can J Public Health1995;86:66.

102. McKeiguePM, LammSH, LinnS, et al.Bendectin and birth defects: a meta‐analysis of the epidemiologic studies. Teratology1994;50:881. CrossRef

103. EinarsonTR, LeederJS, KorenG. Method of meta‐analysis of epidemological studies. Drug Intell Clin Pharm1988;22:813.

104. SahakianV, RouseD, SpiesS, et al.Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double‐blinded placebo‐controlled study. Obstet Gynecol1991;78:33.

105. LeathemA. Safety and efficacy of antiemetics used to treat nausea and vomiting in pregnancy. Clin Pharm1986;5:660.

106. Rumeau‐RouquetteC, GoujardJ, HuelG. Possible teratogenic effect of phenothiazines in human beings. Teratology1977;15:57. CrossRef

107. WitterFR, KingTM, BlakeD. The effects of chronic gastrointestinal medication on the fetus and neonate. Obstet Gynecol1981;58:79.

108. KoussenM. Treatment of nausea and vomiting in pregnancy. Am Fam Physician1993;48:1414.

109. EinarsonA, KorenG, BergmanU. Nausea and vomiting of pregnancy: a comparative European study. Eur J Obstet Gynecol Reprod Biol1998;76:1. CrossRef

110. TanPC, KhinePP, VallikkannuN, et al.Promethazine compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Am J Obstet Gynecol2010;115:975. CrossRef

111. MatokI, GorodischerR, KorenG, et al.The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med2009;360:2528. CrossRef

112. BadellML, RaminSM, SmithJA. Treatment options for nausea and vomiting of pregnancy. Pharmacotherapy2006;26:1273. CrossRef

113. SetoA, EinarsonT, KorenG. Pregnancy outcomes following first trimester exposure to antihistamines: a meta‐analysis. Am J Perinatol1997;14:119. CrossRef

114. RubensteinEB, SlusherBS, RojasC, et al.New approaches to chemotherapy‐induced nausea and vomiting: from neuropharmacology to clinical investigations. Cancer J2006;12:341. CrossRef

115. SullivanCA, JohnsonCA, RoachH, et al.A pilot study of intravenous ondansteron for hyperemesis gravidarum. Am J Obstet Gynecol1996;174:1565. CrossRef

116. EinarsonA, MalatepeC, NaviozY. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. Br J Obstet Gynecol2004;111:940. CrossRef

117. SafariHR, AlsulymanOM, GhermanRB, et al.Experience with oral methylprednisolone in the treatment of refractory hyperemesis gravidarum. Am J Obstet Gynecol1998;178:1054. CrossRef

118. YostNP, McIntireDD, WiansFH, et al.A randomized, placebo‐controlled trial of corticosteroids for hyperemesis due to pregnancy. Obstet Gynecol2003;102:1250. CrossRef

119. GillSK, MaltepeC, KorenG. The effect of heartburn and acid reflux on the severity of nausea and vomiting of pregnancy. Can J Gastroenterol2008;23:270.

120. Russo‐StieglitzKE, LevineAB, WagnerBA, et al.Pregnancy outcome in patients requiring parenteral nutrition. J Matern Fetal Med1999;8:164.

121. HolmgrenC, Aagaard‐TilleryKM, SilverRM, et al.Hyperemesis in pregnancy: an evaluation of treatment strategies with maternal and neonatal outcomes. Am J Obstet Gynecol2008;198:56.e1. CrossRef

122. FreemanHJ. Reproductive changes associated with celiac disease. World J Gastroenterol2010;16:5810. CrossRef

123. CollinP, VilskaS, HeinonenPK, et al.Infertility and coeliac disease. Gut1996;39:382. CrossRef

124. MeloniGF, DessoleS, VargiuN, et al.The prevalence of coeliac disease in infertility. Hum Reprod1999;14:2759. CrossRef

125. ShahS, LefflerD. Celiac disease: an underappreciated issue in women's health. Womens Health (London, Engl)2010;6:753. CrossRef

126. ShamalyH, MahameedA, SharonyA, et al.Infertility and celiac disease: do we need more than one serological marker?Acta Obstet Gynecol Scand2004;83:1184. CrossRef

127. KolhoKL, TiitinenA, TulppalaM, et al.Screening for coeliac disease in women with a history of recurrent miscarriage or infertility. Br J Obstet Gynaecol1999;106:171. CrossRef

128. VancikováZ, ChlumeckýV, SokolD, et al.The serologic screening for celiac disease in the general population (blood donors) and in some high‐risk groups of adults (patients with autoimmune diseases, osteoporosis and infertility) in the Czech republic. Folia Microbiol (Praha)2002;47:753. CrossRef

129. SherKS, MayberryJF. Female fertility, obstetric and gynaecological history in coeliac disease: a case control study. Acta Paediatr Suppl1996;412:76. CrossRef

130. FergusonR, HolmesGK, CookeWT. Coeliac disease: fertility and pregnancy. Scand J Gastroenterol1982;17:65. CrossRef

131. RujnerJ. Age at menarche in girls with celiac disease. Ginekol Pol1999;70:359.

132. GasbarriniA, TorreES, TrivelliniC, et al.Recurrent spontaneous abortion and intrauterine fetal growth retardation as symptoms of coeliac disease. Lancet2000;356:399. CrossRef

133. SheinerE, PelegR, LevyA. Pregnancy outcome of patients with known celiac disease. Eur J Obstet Gynecol Reprod Biol2006;129:41. CrossRef

134. NorgardB, FonagerK, SorensenHT, et al.Birth outcomes of women with celiac disease: a nationwide historical cohort study. Am J Gastroenterol1999;94:2435. CrossRef

135. LudvigssonJF, MontgomerySM, EkbomA. Celiac disease and risk of adverse fetal outcome: a population‐based cohort study. Gastroenterology2005;129:454. CrossRef

136. KhashanAS, HenriksenTB, MortensenPB, et al.The impact of maternal celiac disease on birthweight and preterm birth: a Danish population‐based cohort study. Hum Reprod2010;25:528. CrossRef

137. WolfH, IlsenA, van PampusMG, et al.Celiac serology in women with severe pre‐eclampsia or delivery of a small for gestational age neonate. Int J Gynaecol Obstet2008;103:175. CrossRef

138. MartinelliP, TronconeR, PaparoF, et al.Coeliac disease and unfavourable outcome of pregnancy. Gut2000;46:332. CrossRef

139. GrecoL, VenezianoA, Di DonatoL, et al.Undiagnosed coeliac disease does not appear to be associated with unfavourable outcome of pregnancy. Gut2004;53:149. CrossRef

140. CiacciC, CirilloM, AuriemmaG, et al.Celiac disease and pregnancy outcome. Am J Gastroenterol1996;91:718.

141. KhashanAS, QuigleyEM, McNameeR, et al.Increased risk of miscarriage and ectopic pregnancy among women with irritable bowel syndrome. Clin Gastroenterol Hepatol2012;10:902. CrossRef

142. JewellDJ, YoungG. Interventions for treating constipation in pregnancy. Cochrane Database Syst Rev2001;(2):CD001142.

143. BradleyC, KennedyC, TurceaA, et al.Constipation in pregnancy: prevalence, symptoms and risk factors. Obstet Gynecol2007;110:1351. CrossRef

144. DerbyshireE, DaviesJ, CostarelliV, et al.Diet, physical inactivity and the prevalence of constipation throughout and after pregnancy. Matern Child Nutr2006;2:127. CrossRef

145. AndersonAS. Dietary factors in the aetiology and treatment of constipation during pregnancy. Br J Obstet Gynaecol1986;93:245. CrossRef

146. WestL, WarrenJ, CuttsT. Diagnosis and management of irritable bowel syndrome, constipation, and diarrhea in pregnancy. Gastroenterol Clin North Am1992;21:793.

147. LongoSA, MooreRC, CanzoneriBJ, et al.Gastrointestinal conditions during pregnancy. Clin Colon Rectal Surg2010;23:80. CrossRef

148. CullenG, O'DonoghueD. Constipation and pregnancy. Best Pract Res Clin Gastroenterol2007;21:807. CrossRef

149. Tae‐HeeK, LeeH‐H, ChungS‐H. Constipation during pregnancy: when a typical symptom heralds a serious disease. Obstet Gynecol2012;119(2 Pt 1):374. CrossRef

150. BonapaceES, FisherRS. Constipation and diarrhea in pregnancy. Gastroenterol Clin North Am1998;27:197. CrossRef

151. PratherCM. Pregnancy‐related constipation. Curr Gastroenterol Rep2004;6:402. CrossRef

152. XingJH, SofferEE. Adverse effects of laxatives. Dis Colon Rectum2001;44:1201. CrossRef

153. AcsN, BanhidyF, PuhoEH, et al.Senna treatment in pregnant women and congenital abnormalities in their offspring—a population‐based case‐control study. Reprod Toxicol2009;28:100. CrossRef

154. NelsonMM, ForfarJO. Association between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J1971;1:523. CrossRef

155. HeinonenOP, StoneD, ShapiroS. Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group; 1997: 384.

156. HeinonenOP, StoneD, ShapiroS. Evaluation of drugs in relation to malformations which may originate during early or late embryogenesis. In: KaufmanDW(ed). Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group; 1997: 442.

157. LewisJH, WeingoldAB. The use of gastrointestinal drugs during pregnancy and lactation. Am J Gastroenterol1985;80:912.

158. HeinonenOP, SloneD, ShapiroS. Birth Defects and Drugs in Pregnancy: Maternal Drug Exposure and Congenital Malformations. Littleton, MA: Publishing Sciences Group; 1977: 442.

159. GreenhalfJO, LeonardHS. Laxative in the treatment of constipation in pregnant and breast‐feeding mother. Practitioner1973;210:259.

160. BriggsGG, FreemanRK, YaffeSJ. Docusate sodium. In: BriggsGG, FreemanRK, YaffeSJ(eds). Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 4th ed. Baltimore: Williams & Wilkins; 1994: 299.

161. GatuossoJM, KammMA. Adverse effects of drugs used in the management of constipation and diarrhea. Drug Saf1994;10:47. CrossRef

162. SchoenfeldP. Review article: the safety profile of teaserod. Aliment Pharmacol Ther2004;20(Suppl 7):25. CrossRef

163. LevyN, LembergE, SharfM. Bowel habits in pregnancy. Digestion1977;4:216. CrossRef

164. MehtaN, SahaS, ChienEKS, et al.Disorders of the gastrointestinal tract in pregnancy. In: PowrieRO, GreeneMF, CamannW(eds). DeSwiet's Medical Disorders in Obstetric Practice, 5th ed. Oxford: Wiley‐Blackwell; 2010: 256. CrossRef

165. WaldA. Constipation, diarrhea, and symptomatic hemorrhoids during pregnancy. Gastroenterol Clin N Am2003;32:309. CrossRef

166. WolfJ. Acute diarrhea. In: BranchWT(ed). Office Practice of Medicine. 3rd ed. Philadelphia: WB Saunders; 1994.

167. EinarsonA, MasroiacovoP, ArnonJ, et al.Prsopective, controlled multicentre study of loperamide in pregnancy. Can J Gastroenterol2000;14:185.

168. HaslerWL. The irritable bowel syndrome during preganncy. Gastroenterol Clin North Am2003;32:385. CrossRef

169. MisriS, SivertzK. Tricyclic drugs in pregnancy and lactation: a preliminary report. Int J Psychiatry Med1991;21:157. CrossRef

170. McElhattonPR, GarbisHM, ElefantE, et al.The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). Reprod Toxicol1996;10:285. CrossRef

171. EricsonA, KallenB, WiholmB. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol1999;55:503. CrossRef

172. Study EPIP083. GSK medicine GlaxoSmithKline. Buproprion and paroxetine. Epidemiology study: preliminary report on buproprion in pregnancy and the occurrence of cardiovascular and major congenital malformation, 2005; http://ctr.gsk.co.uk/summary/paroxetine/epip083.pdf.

173. NulmanI, RovetJ, StewartDE, et al.Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med1997;336:258. CrossRef

174. GarlandCF, LilienfeldAM, MendeloffAI, et al.Incidence rates of ulcerative colitis and Crohn's disease in fifteen areas of the United States. Gastroenterology1981;81:1115.

175. MahadevanU. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut2006;55:1198. CrossRef

176. BairdD, NarendranathanM, SandlerRS. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology1990;99:987.

177. HudsonM, FlettG, SinclairTS, et al.Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet1997;58:229. CrossRef

178. Ørding OlsenK, JuulS, BerndtssonI, et al.Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology2002;122:15. CrossRef

179. WaljeeA, WaljeeJ, MorrisAM. Threefold increased risk of infertility: a meta‐analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut2006;55:1575. CrossRef

180. MortierPE, GambiezL, KarouiM, et al.Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis. Gastroenterol Clin2006;30:594.

181. BartelSA, D'HooreA, CuestaMA, et al.Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross‐sectional study. Ann Surg2012;256:1045. CrossRef

182. HeetunZS, ByrnesC, NearyP, et al.Review article: reproduction in the patient with inflammatory bowel disease. Aliment Pharmacol Ther2007;26:513. CrossRef

183. BeaulieuD, KaneSV. Inflammatory bowel disease in pregnancy. Gastroenterol Clin North Am2011;40:399. CrossRef

184. FrenchAE, KorenG. Effect of methotrexate on male fertility. Can Fam Physician2003;49:577.

185. TianenN, MaitikanenN, HiltunenKM. Ileal J‐pouch – anal anastomosis, sexual dysfunction, and fertility. Scand J Gastroenterol1999;34:185. CrossRef

186. GorgunE, RemziFH, MontagueDK, et al.Male sexual function improves after ileal pouch anal anastamosis. Colorectal Dis2005;7:545. CrossRef

187. NielsenOH, AndreassonB, BondesenS, et al.Pregnancy in ulcerative colitis. Scand J Gastroenterol1983;18:735. CrossRef

188. NielsenOH, AndreassonB, BondesenS, et al.Pregnancy in Crohn's disease. Scand J Gastroenterol1984;19:724.

189. MillerJP. Inflammatory bowel disease: a review. J R Soc Med1986;79:221.

190. KhoslaR, WilloughbyCP, JewellDP. Crohn's disease and pregnancy. Gut1984;25:52. CrossRef

191. MogadamM, DobbinsWO, KorelitzBI, et al.Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Obstet Gynecol Surv1981;36:385. CrossRef

192. AlsteadEM. Inflammatory bowel disease in pregnancy. Postgrad Med J2002;78:23. CrossRef

193. BeniadaA, BenoistG, MaurelJ, et al.Inflammatory bowel disease and pregnancy: report of 76 cases and review of the literature. J Gynecol Obstet Biol Reprod (Paris)2005;34:581. CrossRef

194. KaneS, LemieuxN. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol2005;100:102. CrossRef

195. RavidA, RichardCS, SpencerLM, et al.Pregnancy, delivery, and pouch function after ileal pouch‐anal anastomosis for ulcerative colitis. Dis Colon Rectum2002;45:1283. CrossRef

196. KitayamaT, FunayamaY, FukushimaK, et al.Anal function during pregnancy and postpartum after ileal pouch anal anastomosis for ulcerative colitis. Surg Today2005;35:211. CrossRef

197. CornishJ, TanE, TeareJ, et al.A meta‐analysis on the influence of inflammatory bowel disease on pregnancy. Gut2007;56:830. CrossRef

198. DominitzJA, YoungJC, BoykoEJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population‐based cohort study. Am J Gastroenterol2002;97:641. CrossRef

199. NorgardB, FonagerK, PedersenL, et al.Birth outcome in women exposed to 5‐aminosalicylic acid during pregnancy: a Danish cohort study. Gut2003;52:243. CrossRef

200. NørgårdB, PedersenL, ChristensenLA, et al.Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol2007;102:1406. CrossRef

201. HillJA, ClarkA, ScottNA. Surgical treatment of acute manifestations of Crohn's disease during pregnancy. J R Soc Med1997;90:64.

202. SurMD, RomanoffAM, GreensteinAJ, et al.Laparoscopic ileocolic resection for perforated Crohn's disease in pregnancy. J Crohns Colitis2012;7:678. CrossRef

203. Cohen‐KeremR, RailtonC, OrenD, et al.Pregnancy outcome following non‐obstetric surgical intervetion. Am J Surgery2005;190:L467. CrossRef

204. DubinskyM, AbrahamB, MahadevanU. Management of the pregnant IBD patient. Inflamm Bowel Dis2008;14:1736. CrossRef

205. KlementE, CohenRV, BoxmanJ, et al.Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta‐analysis. Am J Clin Nutr2004;80:1342.

206. RahimiR, NikfarS, RezaieA, et al.Pregnancy outcome in women with inflammatory bowel disease following exposure to 5‐aminosalicylic acid drugs: a meta‐analysis. Reprod Toxicol2008;25:271. CrossRef

207. NgSY, MahadevanU. Management of inflammatory bowel disease in pregnancy. Exp Rev Clin Immunol2013;9:161. CrossRef

208. LeviAJ, FisherAM, HughesK, et al.Male infertility due to sulphasalazine. Lancet1979;2:276. CrossRef

209. RagniG, Biancho PorroG, RuspaM, et al.Abnormal Semen Quality and Low Serum Testosterone in Men with Inflammatory Bowel Disease Treated for a Long Time with Sulfasalazine. Andrologia1984;16:162. CrossRef

210. NelisGF. Diarrhoea due to 5‐aminosalicylic acid in breast milk. Lancet1989;1:383. CrossRef

211. BranskiD, KeremE, Gross‐KieselsteinE, et al.Bloody diarrhea – a possible complication of sulfasalazine transferred through human breast milk. J Pediatr Gastroenterol Nutr1985;5:316. CrossRef

212. CarmichaelSL, ShawGM. Maternal corticosteroid use and orofacial clefts. Am J Med Genet1999;86:242. CrossRef

213. CarmichaelSL, ShawGM, MaC, et al.Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol2007;197:585. CrossRef

214. CzeizelA, RockenbauerM. Population‐based case‐control study of teratogenic potential of corticosteroids. Teratology1997;56:335. CrossRef

215. KallenB. Maternal drug use and infant cleft lip/palate with special reference to corticoids. Cleft Palate Craniofac J2003;40:624. CrossRef

216. Park‐WyllieL, MazzottaP, PastuszakA, et al.Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta‐analysis of epidemiological studies. Teratology2000;62:385. CrossRef

217. GithensJH, RosenkrantzJG, TunnockSM. Teratogenic effects of azathioprine (Imuran). J Pediatr1965;66:959. CrossRef

218. RosenkrantzJG, GithensJH, CoxSM, et al.Azathioprine (Imuran) and pregnancy. Am J Obstet Gynecol1967;97:387.

219. GoldsteinLH, DolinskyG, GreenbergR, et al.Pregnancy outcome of women exposed to azathioprine during pregnancy. Birth Defects Res Part A Clin Mol Teratol2007;79:696. CrossRef

220. CoelhoJ, BeaugerieL, ColombelJF, et al., CESAME Pregnancy Study Group (France). Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut2011;60:198. CrossRef

221. McKayDB, JosephsonMA. Pregnancy in recipients of solid organs – effects on mother and child. N Engl J Med2006;354:1533. CrossRef

222. PolifkaJE, FriedmanJM. Teratogen update: Azathioprine and 6‐Mercaptopurine. Teratology2002;65:240. CrossRef

223. NorgardB, PedersenL, FonagerK, et al.Azathioprine, mercaptopurine and birth outcome: a population‐based cohort study. Aliment Pharmacol Ther2003;17:827. CrossRef

224. ChristensenLA, DahlerupJF, NielsenMJ, et al.Azathioprine treatment during lactation. Aliment Pharmacol Ther2008;28:1209. [Epub 2008 Aug 30]. CrossRef

225. SauA, ClarkeS, BassJ, et al.Azathioprine and breastfeeding: is it safe?BJOG2007;114:498. [Epub 2007 Jan 25]. CrossRef

226. AngelbergerS, ReinischW, MesserschmidtA, et al.Long‐term follow‐up of babies exposed to azathioprine in utero and via breastfeeding. J Crohns Colitis2011;5:95. CrossRef

227. BriggsGG, FreemanR, YaffeSJ. Drugs in Pregnancy and Lactation, 7th ed. Lippincott: Williams, Wilkins; 2005.

228. JohnsDG, RutherfordLD, KeightonPC, et al.Secretion of methotrexate into human milk. Am J Obstet Gynecol1972;112:978.

229. Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics1994;93:137.

230. LaiferSA, GuidoRS. Reproductive function and outcome of prengancy after liver transplantation in women. Mayo Clin Proc1995;70:388. CrossRef

231. Ramsey‐GoldmanR, SchillingE. Immunosuppressive drug use during pregnancy. Rheum Dis Clin North Am1997;23:149. CrossRef

232. PetriM. Immunosuppressive drug use in pregnancy. Autoimmunity2003;36:51. CrossRef

233. Bar OzB, HackmanR, EinarsonT, et al.Pregnancy outcome after cyclosporine therapy during pregnancy: a meta‐analysis. Transplantation2001;71:1051. CrossRef

234. BertschingerP, HimmelmannA, RistiB, et al.Cyclosporine treatment of severe ulcerative colitis during pregnancy. Am J Gastroenterol1995;90:330.

235. JayaprakashA, GouldS, LimAG, et al.Use of cyclosporin in pregnancy. Gut2004;53:1386. CrossRef

236. BrancheJ, CortotA, BourreilleA, et al.Cyclosporine treatment of steroid‐refractory ulcerative colitis during pregnancy. Inflamm Bowel Dis2009;15:1044. CrossRef

237. Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics2001;108:776.

238. GisbertJP. Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast‐feeding. Inflamm Bowel Dis2010;16:881. CrossRef

239. GrimerM. Pregnancy, lactation and calcineurin inhibitors. Nephrology2007;12:S98. CrossRef

240. LoebsteinR, AddisA, HoE, et al.Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother1998;42:1336.

241. LarsenH, NielsenGL, SchonhyderHC, et al.Birth outcome following maternal use of fluoroquinolones. Int J Antimicrob Agents2001;18:259. CrossRef

242. CzeizelAE, RockenbauerM. A population based case‐control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol1998;105:322. CrossRef

243. LichtensteinGR, FeaganBG, CohenRD, et al.Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol2006;4:621. CrossRef

244. KatzJA, AntoniC, KeenanGF, et al.Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol2004;99:2385. CrossRef

245. VinetE, PineauC, GordonC, et al.Biologic therapy and pregnancy outcomes in women with rheumatic diseases. Arthritis Rheum2009;61:587. CrossRef

246. MahadevanU, WolfD, DubinskyM, et al.Placental transfer of anti‐tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol2013;11:286. CrossRef

247. KaneS, FordJ, CohenR, et al.Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery. J Clin Gastroenterol2009;43:613. CrossRef

248. VasiliauskasEA, ChurchJA, SilvermanN, et al.Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol2006;4:1255. CrossRef

249. StengelJZ, ArnoldHL. Is infliximab safe to use while breastfeeding?World J Gastroenterol2008;14:3085. CrossRef

250. PeltierM, JamesD, FordJ. Infliximab levels in breast milk of a nursing Crohn's patient. Am J Gastroenterol2001;96:S312. CrossRef

251. Ben‐HorinS, YavzoriM, KopylovU, et al.Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease. J Crohns Colitis2011;5:555. CrossRef

252. MoffattDC, BernsteinCN. Drug therapy for inflammatory bowel disease in pregnancy and the puerperium. Best Pract Res Clin Gastroenterol2007;21:835. CrossRef

253. VesgaL, TerdimanJP, MahadevanU. Adalimumab use in pregnancy. Gut2005;54:890. CrossRef

254. MishkinDS, Van DeinseW, BeckerJM, et al.Successful use of adalimumab (Humira) for Crohn's disease in pregnancy. Inflamm Bowel Dis2006;12:827. CrossRef

255. Ben‐HorinS, YazvoriM, KatzL, et al.Adalimumab level in breast milk of a nursing mother. Clin Gastroenterol Hepatol2010;8:475. CrossRef

256. MahadevanU, CucchiaraS, HyamsJS, et al.The London position statement of the World Congress of gastroenterology on biological therapy for IBD with the European Crohn's and Colitis Organization: pregnancy and pediatrics. Am J Gastroenterol2011;106:214. CrossRef

257. HellwigK, HaghikiaA, GoldR. Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment. Mult Scler2011;17:958. [Epub 2011 May 25]. CrossRef

258. DubinskyM, MahadevanU, VermeireS, et al.Vedolizumab exposure in pregnancy: Outcomes from clinical studies in inflammatory bowel disease [abstract]. Abstracts from the 10th Congress of the European Crohn's and Colitis Organisation. February 18–21, 2015. Barcelona, Spain.

259. LeeN, GagovicV, SahaS. “Gastrointestinal Disorders. In: MattisonDR(ed). Clinical Pharmacology in Pregnancy. London: Elsevier; 2013: 429.

260. GojnicM, DugalicV, PapicM, et al.The significance of detailed examination of hemorrhoids during pregnancy. Clin Exp Obstet Gynecol2005;32:183.

261. AvsarAF, KeskinHL. Hemorroids during pregnancy. J Obstet Gynaecol2010;30:231. CrossRef

262. ChristofidesND, GhateiMA, BloomSR, et al.Decreased plasma motilin concentrations in pregnancy. Br Med J1982;285:1453. CrossRef

263. ParengiS, LevineD, HenrayA, et al.Surgical gastrointestinal disorders during pregnancy. Am J Surgery2007;193:223. CrossRef

264. AbramowitzL, SobhaniI, BeniflaJL, et al.Anal fissure and thrombosed external hemorrhoids before and after delivery. Dis Colon Rectum2002;45:650. CrossRef

265. CorbyH, DonnellyVS, O'HerlihyC, et al.Anal canal pressures are low in women with postpartum anal fissure. Br J Surg1997;84:86. CrossRef

266. CornesH, BartoloDCC, StirratGM. Changes in anal canal sensation after childbirth. Br J Surg1991;78:74. CrossRef

267. SultanAH, KammMA, HudsonCN, et al.Anal‐sphincter disruption during vaginal delivery. N Engl J Med1993;329:1905. CrossRef

268. AllenRE, HoskerGL, SmithAR, et al.Pelvic floor damage and childbirth: a neurophysiological study. Br J Obstet Gynaecol1990;97:770. CrossRef

269. QuigleyEM. Impact of pregnancy and parturition on the anal sphincters and pelvic floor. Best Pract Res Clin Gastroenterol2007;21:879. CrossRef

270. HarkinR, FitzpatrickM, O'ConnellRP, et al.Anal sphincter disruption at vaginal delivery: is recurrence predictable?Eur J Obstet Gynaecol Reprod Biol2003;109:149. CrossRef

271. AndrewsV, SultanAH, ThakarR. Risk factors for obstetric anal sphincter injury: a prospective study. Birth2006;33:117. CrossRef

272. RichterHE, BrumfieldCG, CliverSP, et al.Risk factors associated with anal sphincter tear: A comparison of primiparous patients, vaginal births after caesarean deliveries, and patients with previous vaginal delivery. Am J Obstet Gynecol2002;187:1194. CrossRef

273. AdamsEJ, BrickerL, RichmondDH, et al.Systematic review of third degree tears: risk factors. Int Urogynecol J Pelvic Floor Dysfunct2001;12(Suppl 3):12. CrossRef

274. LeighRJ, TurnbergLA. Fecal incontinence: the unvoiced symptoms. Lancet1982;1:1349. CrossRef

275. AbbottD, Atere‐RobertsN, WillaimsA, et al.Obstetric anal sphincter injury. BMJ2010;341:c3414. CrossRef

276. MaloufAJ, NortonCS, EngelAF, et al.Longterm results of overlapping anterior anal sphincter repair for obstetric trauma. Lancet2000;355:260. CrossRef

277. GoffengAR, AnderschB, AnderssonM, et al.Objective methods cannot predict anal incontinence after primary repair of extensive anal tears. Acta Obstet Gynecol Scand1998;77:439. CrossRef

278. AndrewsV, ThakarR, SultanAH. Management of third and fourth degree tears. Rev Gynaecol Pract2003;3:188. CrossRef

279. SultanAH, SultanSL. Preserving the pelvic floor and perineum during childbirth—elective caesarean section?Br J Obstet Gynaecol1996;103:731. CrossRef

280. ShergillAK, Ben‐MenachemT, ChandrasekharaV, et al.ASGE Standard of Practice Committee). Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc2012;76:18. CrossRef

281. BlackburnST, LoperDL. Maternal, fetal, and neonatal physiology. A clinical perspective. Philadelphia: Saunders, 1992.

282. Van ThielDH, GavalerJS. Pregnancy‐associated sex steroids and their effects on the liver. Semin Liver Dis1987;7:1. CrossRef

283. KopylovU, AvidanB, PapageorgiouNP, et al.Idiopathic liver function test abnormality in pregnancy is associated with assisted reproduction techniques. Fertil Steril2013;99:377. CrossRef

284. Ch'ngCL, et al.Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut2002;51:876. CrossRef

285. RodinA, DuncanA, QuarteroHWP, et al.Serum concentrations of alkaline phosphatase isoenzymes and osteocalcin in normal pregnancy. J Clin Endocrinol Metab1989;68:1123. CrossRef

286. ValenzuelaGJ, MunsonLA, TarbauxNM, et al.Time‐de pendent changes in bone, placental, intestinal, and hepatic alkaline phosphatase activities in serum during human pregnancy. Clin Chem1987;33:1801.

287. PrattDS, KaplanMM. Evaluation of abnormal liver‐enzyme results in asymptomatic patients. N Engl J Med2000;342:1266. [PMID: 10781624]. CrossRef

288. KimHC, NamCM, JeeSH, et al.Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ2004;328:983. doi: 10.1136/bmj.38050.593634.63; [published 17 March 2004.]. CrossRef

289. ACOG Committee on Obstetric Practice. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol2004;104:647. CrossRef

290. De SantisM, CesariE, NobiliE, et al.Radiation effects on development. Birth Defects Res C Embryo Today2007;81:177. CrossRef

291. KanalE, BarkovichAJ, BellC, et al.ACR guidance document for safe MR practices: 2007. AJR Am J Roetgenol2007;188:1447. CrossRef

292. RomineL, ReenaC, KatarinaK, et al.Pregnancy and fetus. In: SemelkaR(ed). Abdominal‐Pelvic MRI, 3rd ed. Hoboken, N.J: Wiley‐Blackwell; 2010: 1559.

293. LongSS, LongC, LaiH, et al.Imaging strategies for right lower quadrant pain in pregnancy. AJR Am J Roentgenol2011;196:4. CrossRef

294. BagciS, TuzunA, ErdilA, et al.Treatment of choledocholithiasis in pregnancy: a case report. Arch Gynecol Obstet2003;267:239.

295. TangSJ, MayoMJ, Rodriguez‐FriasE, et al.Safety and utility of ERCP during pregnancy. Gastrointest Endosc2009;69(3 Pt 1):453. CrossRef

296. ReilyCA. Liver disease in the pregnant patient. American College of Gastroenterology. Am J Gastroenterol1999;94:1728. CrossRef

297. ReyesH, et al.Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med1978;88:487. CrossRef

298. RibaltaJ, et al.S‐adenosyl‐L‐methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double‐blind, placebo‐controlled study with negative results. Hepatology1991;13:1084.

299. RiosecoAJ, et al.Intrahepatic cholestasis of pregnancy: a retrospective case‐control study of perinatal outcome. Am J Obstet Gynecol1994;170:890. CrossRef

300. LaiferSA, et al.Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J Matern Fetal Med2001;10:131. CrossRef

301. LeeRH, GoodwinTM, GreenspoonJ, et al.The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol2006;26:527. CrossRef

302. TurunenK, MölsäA, HelanderK, et al.Health history after intrahepatic cholestasis of pregnancy. Acta Obstet Gynecol Scand2012;91:679. CrossRef

303. RopponenA, SundR, RikonenS, et al.Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population‐based study. Hepatology2006;43:723. CrossRef

304. FiskNM, ByeWB, StoreyGN. Maternal features of obstetric cholestasis: 20 years experience at King George V Hospital. Aust N Z J Obstet Gynaecol1988;28:172. CrossRef

305. BacqY, SapeyT, BréchotMC, et al.Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology1997;26:358. CrossRef

306. GlantzA, MarschallHU, MattssonLA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology2004;40:467. CrossRef

307. TurunenK, SumanenM, HaukilahtiRL, et al.Good pregnancy outcome despite intrahepatic cholestasis. Scand J Prim Health Care2010;28:102. doi: 10.3109/02813431003784001. CrossRef

308. ZeccaE, De LucaD, MarrasM, et al.Intrahepatic cholestasis of pregnancy and neonatal respiratory distress syndrome. Pediatrics2006;117:1669. CrossRef

309. WilliamsonC, HemsLM, GoulisDG, et al.Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG2004;111:676. CrossRef

310. GeenesVL, LimYH, BowmanN, et al.A placental phenotype for intrahepatic cholestasis of pregnancy. Placenta2011;32:1026. CrossRef

311. DixonPH, et al.Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut2009;58:537. CrossRef

312. ElorantaML, et al.Association of single nucleotide polymorphisms of the bile salt export pump gene with intrahepatic cholestasis of pregnancy. Scand J Gastroenterol2003;38:648. CrossRef

313. FloreaniA, CarderiI, PaternosterD, et al.Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy. Dig Liver Dis2008;40:366. [Epub 2007 Dec 20]. CrossRef

314. MullenbachR, et al.ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut2005;54:829. CrossRef

315. Oude ElferinkRP, PaulusmaCC. Function and pathophysiological importance of ABCB4 (MDR3 P‐glycoprotein). Pflugers Arch2007;453:601. CrossRef

316. BacqY, GendrotC, PerrotinF, et al.ABCB4 gene mutations and single‐nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy. J Med Genet2009;46:711. CrossRef

317. DayC, HewinsP, SheikhL, et al.Cholestasis in pregnancy associated with ciclosporin therapy in renal transplant recipients. Transpl Int2006;19:1026. CrossRef

318. GlantzA, et al.Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology2005;42:1399. CrossRef

319. MazzellaG, RizzoN, AzzaroliF, et al.Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology2001;33:504. CrossRef

320. BacqY, SentilhesL, ReyesHB, et al.Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta‐analysis. Gastroenterology2012;143:1492. CrossRef

321. WellgeBE, SterneckM, TeufelA, et al.Pregnancy in primary sclerosing cholangitis. Gut2011;60:1117. CrossRef

322. BartonJR, SibaiBM. Gastrointestinal complications of pre‐eclampsia. Semin Perinatol2009;33:179. CrossRef

323. SibaiBM, DekkerG, KupfermincM. Pre‐eclampsia. Lancet2005;365:785. CrossRef

324. ACOG Committee on Practice Bulletins‐Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol2002;99:159. CrossRef

325. LindheimerMD, TalerSJ, CunninghamFG. Hypertension in pregnancy. J Am Soc Hypertens2008;2:484. CrossRef

326. MackayAP, BergCJ, LiuX, et al.Changes in pregnancy mortality ascertainment: United States, 1999–2005. Obstet Gynecol2011;118:104. CrossRef

327. AnselemO, GirardG, StepanianA, et al.Influence of ethnicity on the clinical and biologic expression of pre‐eclampsia in the ECLAXIR study. Int J Gynaecol Obstet2011;115:153. CrossRef

328. KozicJR, BentonSJ, HutcheonJA, et al.Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia. J Obstet Gynaecol Can2011;33:995.

329. Mei‐DanE, WiznitzerA, SergienkoR, et al.Prediction of preeclampsia: liver function tests during the first 20 gestational weeks. J Matern Fetal Neonatal Med2013;26:250. doi: 10.3109/14767058.2012.733771; [Epub 2012 Oct 18]. CrossRef

330. SibaiBM, RamadanMK, UstaI, et al.Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol1993;169:1000. CrossRef

331. FitzpatrickKE, HinshawK, KurinczukJJ, et al.Risk factors, management, and outcomes of hemolysis, elevated liver enzymes, and low platelets syndrome and elevated liver enzymes, low platelets syndrome. Obstet Gynecol2014;123:618. doi: 10.1097/AOG.0000000000000140. CrossRef

332. SibaiBM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol2004;103(5 Pt 1):981. CrossRef

333. SibaiBM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?Am J Obstet Gynecol1990;162:311. CrossRef

334. AudibertF, FriedmanSA, FrangiehAY, et al.Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol1996;175:460. CrossRef

335. MartinJNJr, RoseCH, BrieryCM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol2006;195:914. CrossRef

336. KruegerKJ, HoffmanBJ, LeeWM. Hepatic infarction associated with eclampsia. Am J Gastroenterol1990;85:588.

337. AlsulymanOM, CastroMA, ZuckermanE, et al.Preeclampsia and liver infarction in early pregnancy associated with the antiphospholipid syndrome. Obstet Gynecol1996;88(4 Pt 2):644. CrossRef

338. Grand'MaisonS, SauvéN, WeberF, et al.Hepatic rupture in hemolysis, elevated liver enzymes, low platelets syndrome. Obstet Gynecol2012;119:617. CrossRef

339. ZarrinparA, FarmerDG, GhobrialRM, et al.Liver transplantation for HELLP syndrome. Am Surg2007;73:1013.

340. HunterSK, MartinM, BendaJA, et al.Liver transplant after massive spontaneous hepatic rupture in pregnancy complicated by preeclampsia. Obstet Gynecol1995;85:819. CrossRef

341. MartinJNJr, OwensMY, KeiserSD, et al.Standardized Mississippi Protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity. Hypertens Pregnancy2012;31:79. CrossRef

342. WoudstraDM, ChandraS, HofmeyrGJ, et al.Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev2010;(9):CD008148.

343. BurwickRM, FeingbergBB. Eculizumab for the treatment of preeclampsia/HELLP syndrome. Placenta2012;34:201. pii: S0143‐4004(12)00449‐3; doi: 10.1016/j.placenta.2012.11.014; [Epub ahead of print]. CrossRef

344. SibaiBM, RamadanMK, ChariRS, et al.Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long‐term prognosis. Am J Obstet Gynecol1995;172(1 Pt 1):125. CrossRef

345. KnightM, Nelson‐PiercyC, KurinczukJJ, et al.UK Obstetric Surveillance System. A prospective national study of acute fatty liver of pregnancy in the UK. Gut2008;57:951. CrossRef

346. PereiraSP, O'DonohueJ, WendonJ, et al.Maternal and perinatal outcome in severe pregnancy‐related liver disease. Hepatology1997;26:1258.

347. RielyCA. Acute fatty liver of pregnancy. Semin Liver Dis1987;7:47. CrossRef

348. KennedyS, HallPM, SeymourAE, et al.Transient diabetes insipidus and acute fatty liver of pregnancy. Br J Obstet Gynaecol1994;101:387. CrossRef

349. MoldenhauerJS, O'brienJM, BartonJR, et al.Acute fatty liver of pregnancy associated with pancreatitis: a life‐threatening complication. Am J Obstet Gynecol2004;190:502. CrossRef

350. TreemWR, ShoupME, HaleDE, et al.Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3‐hydroxyacyl‐coenzyme A dehydrogenase deficiency. Am J Gastroenterol1996;91:2293.

351. IbdahJA, BennettMJ, RinaldoP, et al.A fetal fatty‐acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med1999;340:1723. CrossRef

352. NatarajanSK, ThangarajKR, EapenCE, et al.Liver injury in acute fatty liver of pregnancy: possible link to placental mitochondrial dysfunction and oxidative stress. Hepatology2010;51:191. CrossRef

353. KlineLW, KarpinskiE. Progesterone inhibits gallbladder motility through multiple signaling pathways. Steroids2005;70:673. CrossRef

354. HahmJS, ParkJY, SongSC, et al.Gallbladder motility change in late pregnancy and after delivery. Korean J Intern Med1997;12:16. CrossRef

355. EversonGT. Pregnancy and gallstones. Hepatology1993;17:159. CrossRef

356. KernFJr, EversonGT, DeMarkB, et al.Biliary lipids, bile acids, and gallbladder function in the human female. Effects of pregnancy and the ovulatory cycle. J Clin Invest1981;68:1229. CrossRef

357. Mendez‐SanchezN, Chavez‐TapiaNC, UribeM. Pregnancy and gallbladder disease. Ann Hepatol2006;5:227.

358. MaringhiniA, CiambraM, BaccelliereP, et al.Biliary sludge and gallstones in pregnancy: incidence, risk factors, and natural history. Ann Intern Med1993;119:116. CrossRef

359. ValdiviesoV, CovarrubiasC, SiegelF, et al.Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium. Hepatology1993;17:1.

360. RaminKD, RamseyPS. Disease of the gallbladder and pancreas in pregnancy. Obstet Gynecol Clin North Am2001;28:571. CrossRef

361. LuEJ, CuretMJ, El‐SayedYY, et al.Medical versus surgical management of biliary tract disease in pregnancy. Am J Surg2004;188:755. CrossRef

362. MuenchJ, AlbrinkM, SerafiniF, et al.Delay in treatment of biliary disease during pregnancy increases morbidity and can be avoided with safe laparoscopic cholecystectomy. Am Surg2001;67:539.

363. GlasgowRE, VisserBC, HarrisHW, et al.Changing management of gallstone disease during pregnancy. Surg Endosc1998;12:241. CrossRef

364. KuyS, RomanSA, DesaiR, et al.Outcomes following cholecystectomy in pregnant and nonpregnant women. Surgery2009;146:358. CrossRef

365. DateRS, KaushalM, RameshA. A review of the management of gallstone disease and its complications in pregnancy. Am J Surg2008;196:599. CrossRef

366. WeigandK, DoningerJ, EnckeJ, et al.Acute cholecystitis‐early laparoscopic surgery versus antibiotic therapy and delayed elective cholecystectomy: ACDC‐study. Trials2007;8:29. CrossRef

367. JelinEB, SminkDS, VernonAH, et al.Management of biliary tract disease during pregnancy: a decision analysis. Surg Endosc2008;22:54. CrossRef

368. EddyJJ, GideonsenMD, SongJY, et al.Pancreatitis in pregnancy. Obstet Gynecol2008;112:1075. CrossRef

369. RaminKD, RaminSM, RicheySD, et al.Acute pancreatitis in pregnancy. Am J Obstet Gynecol1995;173:187. CrossRef

370. LegroRS, LaiferSA. First‐trimester pancreatitis. Maternal and neonatal outcome. J Reprod Med1995;40:689.

371. KhanSA, LatifUS, EloubeidiAM. Controversies in the etiologies of acute pancreatitis. J Pancreas2010;11:545.

372. RoumieuF, PonchonT, AudraP, et al.Acute pancreatitis in pregnancy: place of the different explorations (magnetic resonance cholangiopancreatogratphy, endoscopic ultrasounography: and their therapeutic consequences. Eur J Obstet Gynecol Reprod Biol2008;140:141. CrossRef

373. OtoA, ErnstRD, GhulmiyyahLM, et al.MR imaging in the triage of pregnant patients with acute abdominal and pelvic pain. Abdom Imaging2009;34:243. CrossRef

374. HernandezA, PetrovMS, BrooksDC, et al.Acute pancreatitis and pregnancy: a 10‐year single center experience. J Gastrointest Surg2007;11:1623. CrossRef

375. PetrovMS. Gestational pancreatitis: when does etiology matter. Am J Obstet Gynecol2009;200:e9. CrossRef

376. BarthelJS, ChowdhuryT, MiedemaBW. Endoscopic sphincterotomy for the treatment of gallstone pancreatitis during pregnancy. Surg Endosc1998;12:394. CrossRef

377. Vázquez‐LglesiasJL, González‐CondeB, López‐RosésL, et al.Endoscopic sphincterotomy for prevention of the recurrence of acute biliary pancreatitis in patients with gallbladder in situ: long‐term follow‐up of 88 patients. Surg Endosc2004;18:1442.

378. HoekstraJ, SeijoS, RautouPE, et al.Pregnancy in women with portal vein thrombosis: Results of a multicentric European study on maternal and fetal management and outcome. J Hepatol2012;57:1214. CrossRef

379. KhurooMS, DattaDV. Budd–Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract. Am J Med1980;68:113. CrossRef

380. RautouPE, AngermayrB, Garcia‐PaganJC, et al.Pregnancy in women with known and treated Budd‐Chiari syndrome: maternal and fetal outcomes. J Hepatol2009;51:47. CrossRef

381. IjazS, ArnoldE, BanksM, et al.Non‐travel‐associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis2005;192:1166. CrossRef

382. KuniholmMH, PurcellRH, McQuillanGM, et al.Epidemiology of hepatitis E virus in the United States: results from the Third national Health and Nutrition Examination Survey, 1988–1994. J Infect Dis2009;200:48. CrossRef

383. KhurooMS, KamiliS, JameelS. Vertical transmission of hepatitis E virus. Lancet1995;345:1025. CrossRef

384. KumarRM, UdumanS, RanaS, et al.Sero‐prevalence and mother‐to‐infant transmission of hepatitis E virus amoung pregnant women in the United Arab of Emirates. Eur J Obstet Gynecol Reprod Biol2001;100:9. CrossRef

385. BorkakotiJ, HazamRK, MohammadA, et al.Does high viral load of hepatitis E virus influence the severity and prognosis of acute liver failure during pregnancy?J Med Virol2013;85:620. CrossRef

386. MalletV, NicandE, SultanikP, et al.Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med2010;153:85. CrossRef

387. BrownZA, SelkeS, ZehJ, et al.The acquisition of herpes simplex virus during pregnancy. N Engl J Med1997;337:509. CrossRef

388. KangAH, GravesCR. Herpes simplex hepatitis in pregnancy: a case report and review of the literature. Obstet Gynecol Surv1999;54:463. CrossRef

389. KleinNA, MabieWC, ShaverDC, et al.Herps simplex virus hepatitis in pregnancy: two patients successfully treated with acyclovir. Gastroenterology1991;100:239.

390. NienaberJH, McNamaraDR, BanerjeeR, et al.Fulminant gestational hepatitis due to primary herpes simplex type 2 infection: use of serum HSV polymerase chain reaction for noninvasive diagnosis. Diagn Microbiol Infect Dis2012;72:181. CrossRef

391. NorvellJP, BleiAT, JovanovicBD, et al.Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases. Liver Transpl2007;13:1428. CrossRef

392. GreenspoonJS, WilcoxJG, McHutchisonLB, et al.Acyclovir for disseminated herpes simplex virus in pregnancy: a case report. J Reprod Med1994;39:311.

393. Acyclovir and valacyclovir pregnancy registries. http://pregnancyregistry.gsk.com/acyclovir.html. Accessed 22 April 2015.

394. Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR2008;57(RR–8):1. http://www.cdc.gov/hepatitis/HBV/HBVfaq.htm#overview.

395. CohenC, EvansEE, LondonWT, et al.Underestimation of chronic hepatitis B virus infection in the United States of America. J Viral Hepat2008;15:12.

396. SheikhMY, MouanoutouaM, WalvickMD, et al.Prevalence of Hepatitis B Virus (HBV) infection among hmong immigrants in the San Joaquin Valley. J Community Health2011;36:42. CrossRef

397. PollackH, et al.Screening for chronic hepatitis B among Asian/Pacific Islander populations‐New York City, 2005. Morb Mortal Wkly Rep2006;55:504.

398. AlterMJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol2003;39(Suppl 1):S64. CrossRef

399. JonasM. Hepatitis B and pregnancy: an underestimated issue. Liver Int2009;29(Suppl 1):133. CrossRef

400. LokAS, McMahonBJ. Chronic hepatitis B: update 2009. Hepatology2009;50:1.

401. SinghalA, KanagalaR, JalilS, et al.Chronic HBV with pregnancy: reactivation flare causing fulminant hepatic failure. Ann Hepatol2011;10:233.

402. LubelJS, TestroAG, AngusPW. Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management. Int Med J2007;37:705. CrossRef

403. LinHH, WuWY, KaoJH, et al.Hepatitis B post‐partum e antigen clearance in hepatitis B carrier mothers: correlation with viral characteristics. J Gastroenterol Hepatol2006;21:605. CrossRef

404. TanHH, LuiHF, ChowWC. Chronic hepatitis B virus (HBV) infection in pregnancy. Hepatol Int2008;2:370. CrossRef

405. YangY‐B, LiX‐M, ShiZ‐J, et al.Pregnant woman with fulminant hepatic failure caused by hepatitis B virus infection: a case report. World J Gastroenterol2004;10:2305.

406. FontanaRJ. Side effects of long‐term oral antiviral therapy for hepatitis B. Hepatology2009;49:S185. doi: 10.1002/hep.22885. CrossRef

407. Package insert. http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/pegihof101602lb.htm Accessed 22 April 2015.

408. SuG‐G, PanK‐H, ZhaoN‐F, et al.Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol2004;10:910.

409. MunderiP, WilkesH, TumukundeD, et al.Pregnancy and outcomes among women on triple‐drug antiretroviral therapy (ART) in the DART trial [poster WEPEB261]. Presented at the Fifth IAS Conference on HIV Pathogenesis, Treatment and Prevention. Cape Town, South Africa; July 19–22, 2009.

410. The Antiretroviral Pregnancy Registry. http://www.apregistry.com/.

411. TerraultNA, JacobsonIM. Treating chronic hepatitis B infection in patients who are pregnant or are undergoing immunosuppressive chemotherapy. Semin Liver Dis2007;27(Suppl 1):18. CrossRef

412. OrnoyA, TenebaumA. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol2006;21:446. CrossRef

413. Gambarin‐GelwanM. Hepatitis B in pregnancy. Clin Liver Dis2007;11:945. CrossRef

414. SookoianS. Effect of pregnancy on pre‐existing liver disease: chronic viral hepatitis. Ann Hepatol2006;5:190.

415. ReddickKL, JhaveriR, GandhiM, et al.Pregnancy outcomes associated with viral hepatitis. J Viral Hepat2011;18:e394. CrossRef

416. SookoianS. Liver disease during pregnancy: acute viral hepatitis. Ann Hepatol2006;5:231.

417. WongS, ChanLY, YuV, et al.Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol1999;16:485. CrossRef

418. LevyM, KorenG. Hepatitis B vaccine in pregnancy: maternal and fetal safety. Am J Perinatol1991;8:227. CrossRef

419. BaiH, ZhangL, MaL, et al.Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra‐uterine transmission mechanism. World J Gastroenterol2007;13:3625. CrossRef

420. BeasleyRP, HwangLY, LeeGC, et al.Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet1983;2:1099. CrossRef

421. StevensCE, TaylorPE, TongMJ, et al.Yeast‐recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA1987;257:2612. CrossRef

422. MastEE, HwangLY, SetoDS, et al.Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis2005;192:1880. CrossRef

423. BurkRD, HwangLY, HoGY, et al.Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis1994;170:1418. CrossRef

424. WisemanE, FraserMA, HoldenS, et al.Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust2009;190:489.

425. MastEE, MargolisHS, FioreAE, et al.A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR2005;54(RR–16):1. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5416a1.htm?s_cid=rr5416a1_e; (table 3).

426. del CanhoR, GrosheidePM, MazelJA, et al.Ten‐year neonatal hepatitis B vaccination program, The Netherlands, 1982–1992: protective efficacy and long‐term immunogenicity. Vaccine1997;15:1624. CrossRef

427. WangZ, ZhangJ, YangH, et al.Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol2003;71:360. CrossRef

428. ZouH, ChenY, DuanZ, et al.Virologic factors associated with failure to passive‐active immunoprophylaxis in infants born to HBsAg‐positive mothers. J Viral Hepat2012;19:e18. CrossRef

429. HanL, ZhangHW, XieJX, et al.A meta‐analysis of lamivudine for interruption of mother‐to‐child transmission of hepatitis B virus. World J Gastroenterol2011;17:4321. CrossRef

430. LuYP, LiangXJ, XiaoXM, et al.Telbivudine during the second and third trimester of pregnancy interrupts HBV intrauterine transmission: a systematic review and meta‐analysis. Clin Lab2014;60:571. PMID: 24779291.

431. HannHW, GregoryVL, DixonJS, et al.A review of the one‐year incidence of resistance to lamivudine in the treatment of chronic hepatitis B Lamivudine resistance. Hepatol Int2008;2:440. CrossRef

432. GalluzzoC, LiottaG, AndreottiM, et al.Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother‐to‐infant transmission in Malawi. J Med Virol2012;84:1553. CrossRef

433. PanCQ, HanGR, JiangHX, et al.Telbivudine prevents vertical transmission from HBeAg‐positive women with chronic hepatitis B. Clin Gastroenterol Hepatol2012;10:520. CrossRef

434. PanCQ, MiLJ, BunchorntavakulC, et al.Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series. Dig Dis Sci2012;57:2423. CrossRef

435. BrownRSJr, VernaEC, PereiraMR, et al.Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy Registry. J Hepatol2012;57:953. CrossRef

436. XuH, ZengT, LiuJY, et al.Measures to reduce mother‐to‐child transmission of Hepatitis B virus in China: a meta‐analysis. Dig Dis Sci2014;59:242. doi: 10.1007/s10620‐013‐2918‐0; [Epub 2013 Nov 6]; PMID: 24193353. CrossRef

437. GartnerLM, MortonJ, LawrenceRA, et al.American Academy of Pediatrics Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics2005;115:496. CrossRef

438. SokalEM, PaganelliM, WirthS, et al., European Society of Pediatric Gastroenterology, Hepatology and Nutrition. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Hepatol2013;59:814. doi: 10.1016/j.jhep.2013.05.016; [Epub 2013 May 23]. CrossRef

439. ShiX, YangY, WangH, et al.Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta‐analysis and systematic review. Arch Pediatr Adolesc Med2011;165:837. CrossRef

440. EhrhardtS, XieC, GuoN, et al.Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence. Clin Infect Dis2014;60:275. pii: ciu798; [Epub ahead of print]. CrossRef

441. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5416a1.htm Accessed 3 March 2015.

442. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5416a2.htm. Accessed 3 March 2015.

443. AlterMJ, Kruszon‐MoranD, NainanOV, et al.The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med1999;341:556. CrossRef

444. CostaZB, MachadoGC, AvelinoMM, et al.Prevalence and risk factors for Hepatitis C and HIV‐1 infections among pregnant women in Central Brazil. BMC Infect Dis2009;9:116. CrossRef

445. SchwimmerJB, BalistreriWF. Transmission, natural history, and treatment of hepatitis C virus infection in the pediatric population. Semin Liver Dis2000;20:37. CrossRef

446. UgbeborO, AigbiriorM, OsazuwaF, et al.The prevalence of hepatitis B and C viral infections among pregnant women. N Am J Med Sci2011;3:238. CrossRef

447. FontaineH, NalpasB, CarnotF, et al.Effect of pregnancy on chronic hepatitis C: a case‐control study. Lancet2000;356:1328. CrossRef

448. PaternosterDM, SantarossaC, GrellaP, et al.Viral load in HCV RNA‐positive pregnant women Viral load in HCV RNA‐positive pregnant women. Am J Gastroenterol2001;96:2751. CrossRef

449. PergamSA, WangCC, GardellaCM, et al.Pregnancy complications associated with hepatitis C: Data from a 2003–2005 Washington state birth cohort. Am J Obstet Gynecol2008;199:38.e1. doi: 10.1016/j.ajog.2008.03.052. CrossRef

450. ConteD, FraquelliM, PratiD, et al.Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology2000;31:751. doi: 10.1002/hep.510310328. CrossRef

451. WesjtalR, WidellA, ManssonAS, et al.Nokrans G. Mother‐to‐infant transmission of hepatitis C virus. Ann Intern Med1992;117:887. CrossRef

452. OhtoH, TerazawaS, SasakiN, et al., Vertical Transmission of Hepatitis C Virus Collaborative Study Group. Transmission of hepatitis C virus from mothers to infants. N Engl J Med1994;330:744. CrossRef

453. Ruiz‐ExtremeraA, Muñoz‐GámezJA, Salmerón‐RuizMA, et al.Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV‐infected children. Hepatology2011;53:1830. CrossRef

454. RobertsEA, YeungL. Maternal‐infant transmission of hepatitis C virus infection. Hepatology2002;36(5 Suppl 1):S106. CrossRef

455. CottrellEB, ChouR, WassonN, et al.Reducing risk for mother‐to‐infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med2013;158:109. CrossRef

456. Ghamar ChehrehME, TabatabaeiSV, KhazanehdariS, et al.Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV‐RNA+/HIV− mothers: a meta‐analysis. Arch Gynecol Obstet2011;283:255. CrossRef

457. European Paediatric Hepatitis C Virus Network. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis2005;41:45. CrossRef

458. HanafiNF, Abo AliAH, Abo el kheirHF. ICSI outcome in women who have positive PCR result for hepatitis C virus. Hum Reprod2011;26:143. [Epub 2010 Nov 26]. CrossRef

459. SavasiV, OnetaM, ParrillaB, et al.Should HCV discordant couples with a seropositive male partner be treated with assisted reproduction techniques (ART). Eur J Obstet Gynecol Reprod Biol2013;167:181. pii: S0301‐2115(12)00576‐3; doi: 10.1016/j.ejogrb.2012.12.012; [Epub ahead of print]. CrossRef

460. VernonG, BaranovaA, YounossiZM. Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and nonalcoholic steatohepatitis in adults. Aliment Pharmacol Ther2011;34:274. CrossRef

461. BrzozowskaMM, OstapowiczG, WeltmanMD. An association between non‐alcoholic fatty liver disease and polycystic ovarian syndrome. J Gastroenterol Hepatol2009;24:243. CrossRef

462. PageLM, GirlingJC. A novel cause for abnormal liver function tests in pregnancy and the puerperium: non‐alcoholic fatty liver disease. BJOG2011;118:1532. CrossRef

463. MouralidaraneA, SoedaJ, Visconti‐PugmireC, et al.Maternal obesity programs offspring non‐alcoholic fatty liver disease via innate immune dysfunction in mice. Hepatology2013;58:128. doi: 10.1002/hep.26248; [Epub ahead of print]. CrossRef

464. BruceKD, CagampangFR, ArgentonM, et al.Maternal high‐fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression. Hepatology2009;50:1796. doi: 10.1002/hep.23205. CrossRef

465. AlisiA, CianfaraniS, MancoM, et al.Non‐alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment. Ann Med2012;44:29. CrossRef

466. StokkelandK, EbrahimF, HultcrantzR, et al.Mothers with alcoholic liver disease and the risk for preterm and small‐for‐gestational‐age birth. Alcohol Alcohol2013;48:166. [Epub ahead of print]. CrossRef

467. Al‐ChalabiT, UnderhillJA, PortmannBC, et al.Impact of gender on the long‐term outcome and survival of patients with autoimmune hepatitis. J Hepatol2008;48:140. CrossRef

468. HeneganMA, NorrisSM, O'GradyJG, et al.Management and outcome of pregnancy in autoimmune hepatitis. Gut2000;48:97. CrossRef

469. WestbrookRH, YeomanAD, KrieseS, et al.Outcomes of pregnancy in women with autoimmune hepatitis. J Autoimmun2012;38:J239. CrossRef

470. Le RayC, CoulombA, ElefantE, FrydmanR, AudibertF. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations. Obstet Gynecol2004;103:1091. CrossRef

471. EdmondsonHA, HendersonB, BentonB. Liver‐cell adenomas associated with use of oral contraceptives. N Engl J Med1976;294:470. CrossRef

472. BisKA, WaxmanB. Rupture of the liver associated with pregnancy: a review of the literature and report of 2 cases. Obstet Gynecol Surv1976;31:763. CrossRef

473. KerlinP, DavisGL, McGillDB, et al.Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology1983;84(5 Pt 1):994.

474. FosterJH, BermanMM. The malignant transformation of liver cell adenomas. Arch Surg1994;129:712. CrossRef

475. NoelsJE, van AaltenSM, van der WindtDJ, et al.Management of hepatocellular adenoma during pregnancy. J Hepatol2011;54:553. CrossRef

476. WilsonCH, ManasDM, FrenchJJ. Laparoscopic liver resection for hepatic adenoma in pregnancy. J Clin Gastroenterol2011;45:828. CrossRef

477. KondoF, NagaoT, SatoT, et al.Etiological analysis of focal nodular hyperplasia of the liver, with emphasis on similar abnormal vasculatures to nodular regenerative hyperplasia and idiopathic portal hypertension. Pathol Res Pract1998;194:487. CrossRef

478. NakanumaY. Non‐neoplastic nodular lesions in the liver. Pathol Int1995;45:703. CrossRef

479. RifaiK, MixH, KruscheS, et al.No evidence of substantial growth progression or complications of large focal nodular hyperplasia during pregnancy. Scand J Gastroenterol2013;48:88. CrossRef

480. RussellMA, CraigoSD. Cirrhosis and portal hypertension in pregnancy. Semin Perinatol1998;22:156. CrossRef

481. ShaheenAA, MyersRP. The outcomes of pregnancy in patients with cirrhosis: a population‐based study. Liver Int2010;30:275. CrossRef

482. PajorA, LehoczkyD. Pregnancy and extrahepatic portal hypertension. Gynecol Obstet Invest1990;30:193. CrossRef

483. PajorA, LehoczkyD. Pregnancy in liver cirrhosis. Gynecol Obstet Invest1994;38:45. CrossRef

484. MurthySK, HeathcoteEJ, NguyenGC. Impact of cirrhosis and liver transplant on maternal health during labor and delivery. Clin Gastroenterol Hepatol2009;7:1367, 1372.e1. CrossRef

485. BrittonRC. Pregnancy and esophageal varices. Am J Surg1982;143:421. CrossRef

486. MisraS, SanyalAJ. Pregnancy in a patient with portal hypertension. Clin Liver Dis1999;3:147. CrossRef

487. WestbrookRH, YeomanAD, O'GradyJG, et al.Model for end‐stage liver disease score predicts outcome in cirrhotic patients during pregnancy. Clin Gastroenterol Hepatol2011;9:694. CrossRef

488. WestbrookRH, YeomanAD, JoshiD, et al.Outcomes of severe pregnancy‐related liver disease: refining the role of transplantation. Am J Transplant2010;10:2520. CrossRef

489. CundyTF, O'GradyJG, WilliamsR. Recovery of menstruation and pregnancy after liver transplantation. Gut1990;31:337. CrossRef

490. DeshpandeNA, JamesNT, KucirkaLM, et al.Pregnancy outcomes of liver transplant recipients: a systematic review and meta‐analysis. Liver Transpl2012;18:621. CrossRef